Endoscopic disinfection is a critical procedure in healthcare to ensure the safety of patients undergoing endoscopic examinations. This process involves meticulous cleaning and sterilization of endoscopes, medical instruments used for internal visualizations. Employing high-level disinfectants or sterilizing agents, the aim is to eliminate or minimize the presence of harmful microorganisms on endoscope surfaces. Comprehensive disinfection protocols encompass steps such as pre-cleaning, leak testing, high-level disinfection or sterilization, and proper drying. Strict adherence to these guidelines is paramount to prevent healthcare-associated infections and cross-contamination. Both manual and automated disinfection techniques are utilized, with the effectiveness of the procedure crucial for maintaining aseptic conditions. Proper storage of disinfected endoscopes in designated areas further contributes to ensuring the integrity of these instruments for diagnostic and therapeutic procedures. Continuous advancements in disinfection technologies, coupled with rigorous adherence to standardized protocols, play a pivotal role in upholding the highest standards of patient care and infection control in healthcare settings.
Khursheed Nadeem Anwer
IMUNON, United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Ahmed Abdulazeez
BHRUT Trust, United KingdomSubmit your abstract Today
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey